Megens A A, Leysen J E, Awouters F H, Niemegeers C J
Eur J Pharmacol. 1986 Sep 23;129(1-2):57-64. doi: 10.1016/0014-2999(86)90336-5.
Eighteen chemically dissimilar alpha-adrenoceptor agonists were assessed in 6 different tests. The antidiarrheal activity of the compounds was highly correlated with the diuretic activity. Both activities were highly correlated with the inhibition of [3H]clonidine or [3H]idazoxan binding; the degree of correlation with inhibition of [3H]WB4101 binding or with antiptotic activity was much less. Antiptotic activity was better correlated, although still poorly, with inhibition of [3H]WB4101 binding than with inhibition of [3H]clonidine or [3H]idazoxan binding. The in vivo antiptotic/diuretic or antiptotic/antidiarrheal potency ratios both reflected the known alpha 2/alpha 1-selectivity of the compounds tested and were significantly correlated with the in vitro potency ratios between inhibition of [3H]WB4101 binding on one hand and of [3H]clonidine or [3H]idazoxan binding on the other. The reliability of the above models for measuring alpha 1- and alpha 2-adrenoceptor agonistic activity and selectivity is discussed.
在6种不同的试验中对18种化学结构不同的α-肾上腺素能受体激动剂进行了评估。这些化合物的止泻活性与利尿活性高度相关。这两种活性均与对[³H]可乐定或[³H]咪唑克生结合的抑制高度相关;与对[³H]WB4101结合的抑制或抗凋亡活性的相关性程度则低得多。抗凋亡活性与对[³H]WB4101结合的抑制的相关性较好,尽管仍然很差,但比对[³H]可乐定或[³H]咪唑克生结合的抑制的相关性要好。体内抗凋亡/利尿或抗凋亡/止泻效价比均反映了所测试化合物已知的α₂/α₁选择性,并且与一方面对[³H]WB4101结合的抑制与另一方面对[³H]可乐定或[³H]咪唑克生结合的抑制之间的体外效价比显著相关。讨论了上述用于测量α₁和α₂肾上腺素能受体激动活性及选择性的模型的可靠性。